Latest Articles
Novotech Publishes Report on Research into Endometrial - GlobeNewswire
Novotech Publishes Report on Research into Endometrial GlobeNewswire
Published: June 20, 2024, 7 a.m.
FDA Approves Two First-Line Immunotherapies for Endometrial Cancer - Cancer Health Treatment News
FDA Approves Two First-Line Immunotherapies for Endometrial Cancer Cancer Health Treatment News
Published: June 20, 2024, 7 a.m.
Cost-effectiveness of dostarlimab plus chemotherapy for primary advanced or recurrent endometrial cancer - Frontiers
Cost-effectiveness of dostarlimab plus chemotherapy for primary advanced or recurrent endometrial cancer Frontiers
Published: June 20, 2024, 7 a.m.
Ankura Hospital, Bhubaneswar Launches A State-Of-The-Art Facility Specializing In Advanced Gynaecological Care For Endometriosis And Complex Laparoscopic Surgeries - Odisha Diary
Ankura Hospital, Bhubaneswar Launches A State-Of-The-Art Facility Specializing In Advanced Gynaecological Care For Endometriosis And Complex Laparoscopic Surgeries Odisha Diary
Published: June 20, 2024, 7 a.m.
Up to 12% of People Have Bowel Endometriosis—Here’s What To Know - Health.com
Up to 12% of People Have Bowel Endometriosis—Here’s What To Know Health.com
Published: June 19, 2024, 7 a.m.
IVF live birth rate lower with deep infiltrating endometriosis, endometrioma - Healio
IVF live birth rate lower with deep infiltrating endometriosis, endometrioma Healio
Published: June 19, 2024, 7 a.m.
Shamita Shetty Undergoes Surgery For Endometriosis; Wants Women To Be Aware About This Condition | TheHeal - TheHealthSite
Shamita Shetty Undergoes Surgery For Endometriosis; Wants Women To Be Aware About This Condition | TheHeal TheHealthSite
Published: June 19, 2024, 7 a.m.
Dr. Roach: Debilitating menstrual pain might be due to endometriosis - Detroit News
Dr. Roach: Debilitating menstrual pain might be due to endometriosis Detroit News
Published: June 18, 2024, 7 a.m.
Androgen-responsive FOXP4 is a target for endometrial carcinoma | Communications Biology - Nature.com
Androgen-responsive FOXP4 is a target for endometrial carcinoma | Communications Biology Nature.com
Published: June 18, 2024, 7 a.m.
Two New Immunotherapy-Chemo Options Approved for Endometrial Cancer - Medpage Today
Two New Immunotherapy-Chemo Options Approved for Endometrial Cancer Medpage Today
Published: June 18, 2024, 7 a.m.
Link copied to clipboard!